Trend
Immunosenescence

https://doi.org/10.1016/S0167-5699(97)01145-6Get rights and content

Abstract

The deterioration of the immune system in ageing — ‘immunosenescence’ — is thought to contribute to increased morbidity and mortality from infections, and possibly autoimmune disease and cancer, in the elderly. A recent meeting discussed the molecular basis of this process.

References (0)

Cited by (165)

View all citing articles on Scopus

EUCAMBIS is supported by the European Union Biomedical and Health Research Programme Biomed 1 (contract CT94-1209). This report has been composed on behalf of all EUCAMBIS members (E. Mariani, Y. Barnett, C. Bartoloni, G. ligthart, C. Paraskeva, E. Remarque, S. Shall, V. Sorrentino, G.M. Taylor and the two authors).

The 5th EUCAMBIS Congress on the Molecular Biology of Immunosenescence was held at Córdoba, Spain, on 14–18 May 1997.

View full text